In order to use ERPs for diagnostic purposes, however, there are still two big challenges:
Firstly, databases are required that have a sufficient amount of data from healthy individuals as well as data from people who have been diagnosed with a certain disorder.
Secondly, methods which are capable of recognizing significant differences due to specific disorders have to be devised.
Only when enough data is present can we use it to determine parameters, which are markers for a disorder and support diagnoses with statistically significant readings.
We still stand at the beginning of this development, but the BEE Group strongly supports and invests in the researching, validating and using of these biomarkers, especially through its investments in the Swiss HBImed AG and studies.